Get access to our best features
Get Started
Register
Get access to our best features
Get Started
GEN - Genetic Engineering and Biotechnology News… image

GEN - Genetic Engineering and Biotechnology News…

Information about GEN - Genetic Engineering and Biotechnology News…Where is GEN - Genetic Engineering and Biotechnology News… located?GEN - Genetic Engineering and Biotechnology News…'s Website

Factuality

How credible is the news from GEN - Genetic Engineering and Biotechnology News…?
High
by Ad Fontes Media and Media Bias/Fact Check
Learn more about Factuality Ratings.

Media Bias Ratings

Does GEN - Genetic Engineering and Biotechnology News… lean left or right?
Learn more about Media Bias Ratings.

Top GEN - Genetic Engineering and Biotechnology News… News

Newborns Receive Mom's Microbiome Regardless of Birth Method
Science

Newborns Receive Mom's Microbiome Regardless of Birth Method

Whether born vaginally or via cesarean section, babies receive essential microbes from their mothers.See the Story
World’s Longest Oligo Produced Using de novo Synthesis

World’s Longest Oligo Produced Using de novo Synthesis

The DNA synthesis company Ansa Biotechnologies announced de novo synthesis of the world’s longest oligo ever reported to be produced in a single synthesis.See the Story
Novel Insights on How Immune Cells Respond to Cancer Cells Uncovered
Cancer

Novel Insights on How Immune Cells Respond to Cancer Cells Uncovered

A research team led by UCLA Jonsson Comprehensive Cancer Center scientists has identified and analyzed the steps by which immune cells “see” and respond to cancer cells. Their findings may lead to more personalized immunotherapies for patients whose immune systems do not appear to respond to treatment.See the Story

Latest News Stories

Veterans

Head trauma, PTSD may increase genetic variant’s impact on Alzheimer’s risk

100% Center coverage: 1 sources
PTSD, TBI, and the �4 variant of the APOE gene showed strong associations with Alzheimer's Disease and related dementias. Researchers carried out the study by accessing data from VA's Million Veteran Program (MVP), one of the world's largest databases of health and genetic information. More than 40% of the Veteran population above the age of 75 is at risk for Alzheimer's and other forms of dementia.
See the Story

Thermostable TB Vaccine Found Safe and Immunogenic in Humans

The Access to Advanced Health Institute (AAHI) published the results of a Phase I clinical trial demonstrating the safety and immunogenicity of a new, thermostable vaccine against tuberculosis (TB) The TB vaccine comprises multiple proteins from the causative Mycobacterium tuberculosis(Mtb) bacterium as a fusion protein (designated ID93) combined with a proprietary immune-stimulating adjuvant (called GLA-SE) This single-vial freeze dried formulation can be stored at temperatures of nearly 100 degrees Fahrenheit for months, and is mixed with sterile water just prior to injection.
See the Story

The Unbearable Cost of Drug Development: Deloitte Report Shows 15% Jump in R&D to $2.3 Billion

The average cost of developing a new drug among the top 20 global biopharmas rose 15% last year, to approximately $2.3 billion. The return on investment for new drugs and vaccines plunged last year by 82%, to 1.2% from 10.1% in 2010. Deloitte counted 278 late-stage assets last year.
See the Story

Enzyme Found to Play Critical Role in Insulin-Regulated Metabolism

Researchers at the University of Tokyo report they have uncovered an enzyme called Akt2 that when activated, plays a vital role in initiating glycolysis which involves breaking down glucose to produce energy, and nucleotide metabolism which involves synthesizing or breaking down DNA and RNA. The findings may pave the way for Akt2-targeting therapeutics for diabetes and metabolic disorders.
See the Story

Cell and Gene Therapy Manufacturing Costs Limiting Access

High production costs are limiting patient access to cell and gene therapies. Researchers say optimizing manufacturing methods and increasing capacity industry-wide would help. Analysis by the Institute for Clinical and Economic Review (ICER) suggests the average cost of a gene therapy is between $1 million and $2 million per dose.
See the Story

Immunotherapy-Resistant Cancer Patients Lack Critical Immune Cells

The amount of CD5+ dendritic cells inside tumors could be used to help doctors assess which patients are most likely to benefit from immunotherapy.
See the Story

Disrupting Chronic Inflammation in Multiple Sclerosis

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system. Scientists have struggled to understand the causes of MS, but recent research suggests an important role for the gut microbiome. University of Virginia Health System neuroscientists report they have discovered a potential way to disrupt the chronic inflammation responsible for MS.
See the Story

Glioma-Related Epilepsy Insights Revealed

Seizures are a frequent pathophysiological feature of malignant glioma. Researchers at Baylor College of Medicine report that the tumors from seizure patients can interfere with the ability of surrounding neurons to handle potassium. The findings support further studies into novel strategies to control seizures and tumor growth.
See the Story

Breaking News Topics Related to GEN - Genetic Engineering and Biotechnology News…

EdnaEdna
Jackson County, TexasJackson County, Texas
United StatesUnited States
HIVHIV
Artificial IntelligenceArtificial Intelligence
CancerCancer
ScienceScience
Texas, United StatesTexas, United States
Trending Topics
Ground News logo
US
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogSubscribeGiftFree TrialCareersFor Educators/Libraries
HelpHelp CenterFAQContact UsMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsBrowser ExtensionRehashMediaopolyTwitter BlindspotterDaily NewsletterBlindspot Report NewsletterBurst Your Bubble Newsletter
DonatePrivacy PolicyTerms and Conditions
© 2023 Snapwise Inc.
News
Feed
SearchBlindspotLocal